XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Non-controlling Interest (Tables)
12 Months Ended
Dec. 31, 2024
Noncontrolling Interest [Abstract]  
Schedule Of Approximate Interests In Certain Consolidated Subsidiaries

Non-controlling interest recorded in our consolidated financial statements for the years ended December 31, 2024, 2023 and 2022, relates to the following approximate interests in certain consolidated subsidiaries, which we do not own.

 

 

2024

 

 

2023

 

 

2022

 

MiNK Therapeutics, Inc.

 

 

45

%

 

 

37

%

 

 

22

%

SaponiQx, Inc.

 

 

30

%

 

 

30

%

 

 

30

%

Schedule Of Changes In Non-controlling Interest

Changes in non-controlling interest for the years ended December 31, 2024, 2023 and 2022 were as follows (in thousands):

 

 

2024

 

 

2023

 

 

2022

 

Beginning balance

 

$

11,949

 

 

$

6,376

 

 

$

13,469

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to non-controlling interest

 

 

(5,059

)

 

 

(11,676

)

 

 

(10,582

)

 

 

 

 

 

 

 

 

 

 

Other items:

 

 

 

 

 

 

 

 

 

Sale of subsidiary shares in private placement

 

 

10,234

 

 

 

 

 

 

 

Distribution of subsidiary shares to Agenus stockholders

 

 

 

 

 

14,888

 

 

 

 

Purchase of subsidiary shares

 

 

 

 

 

(2,546

)

 

 

 

Issuance of subsidiary shares for employee stock purchase plan and exercise of options

 

 

20

 

 

 

71

 

 

 

 

Issuance of subsidiary shares for employee bonus

 

 

 

 

 

1,011

 

 

 

294

 

Subsidiary share-based compensation

 

 

2,812

 

 

 

3,825

 

 

 

3,195

 

Total other items

 

 

13,066

 

 

 

17,249

 

 

 

3,489

 

 

 

 

 

 

 

 

 

 

 

Ending balance

 

$

19,956

 

 

$

11,949

 

 

$

6,376